Theofano Orfanelli
Stony Brook Medicine, Rutgers, The State University of New Jersey
Papers
2
Total Citations
6
H-Index
2
About
Dr. Theofano Orfanelli is a leading surgical oncologist whose work centers on advancing minimally invasive techniques for complex abdominal and gynecologic cancers. Her primary research focuses on the application of robotic surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), a demanding procedure for peritoneal surface malignancies. In her highly cited 2023 paper, "The robotic future of minimally invasive cytoreduction and hyperthermic intraperitoneal chemotherapy," Dr. Orfanelli explores how robotic platforms can reduce the morbidity of these extensive operations, potentially expanding access to life-extending treatment for patients with mucinous neoplasms of the appendix, ovarian, gastric, and colorectal cancers. Her work also addresses critical postoperative complications, as seen in her 2017 study on Ogilvie's Syndrome after robotic-assisted radical hysterectomy for cervical cancer. With each of her key papers garnering 3 citations, Dr. Orfanelli’s contributions are shaping the next generation of surgical protocols, emphasizing precision, safety, and improved patient recovery. Her research bridges the gap between aggressive oncologic resection and the benefits of robotic assistance, marking her as a pivotal figure in the evolution of minimally invasive surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2